231 related articles for article (PubMed ID: 22550365)
21. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
22. [Percutaneous ablation of renal tumors: radiofrequency ablation or cryoablation?].
Buy X; Lang H; Garnon J; Gangi A
J Radiol; 2011 Sep; 92(9):774-88. PubMed ID: 21944236
[TBL] [Abstract][Full Text] [Related]
23. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
Kunkle DA; Uzzo RG
Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
25. Outcomes following minimally invasive imagine-guided percutaneous ablation of adrenal glands.
Ierardi AM; Carnevale A; Angileri SA; Pellegrino F; Renzulli M; Golfieri R; Zhang D; Sun H; Giganti M; Dionigi G; Carrafiello G
Gland Surg; 2020 Jun; 9(3):859-866. PubMed ID: 32775281
[TBL] [Abstract][Full Text] [Related]
26. [Percutaneous radiofrequency ablation of the renal tumors. Initial clinical experience with minimally invasive therapy].
Hoffmann P; Dvorák P; Morávek P; Safránek H
Rozhl Chir; 2007 Sep; 86(9):494-9. PubMed ID: 17974143
[TBL] [Abstract][Full Text] [Related]
27. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
28. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
29. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations.
Allaf ME; Varkarakis IM; Bhayani SB; Inagaki T; Kavoussi LR; Solomon SB
Radiology; 2005 Oct; 237(1):366-70. PubMed ID: 16126920
[TBL] [Abstract][Full Text] [Related]
30. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation.
Mauri G; Nicosia L; Varano GM; Bonomo G; Della Vigna P; Monfardini L; Orsi F
Insights Imaging; 2017 Jun; 8(3):357-363. PubMed ID: 28500486
[TBL] [Abstract][Full Text] [Related]
31. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
32. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
[TBL] [Abstract][Full Text] [Related]
33. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors.
Sabharwal R; Vladica P
Cardiovasc Intervent Radiol; 2006; 29(2):202-9. PubMed ID: 16447001
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation.
Dunne RM; Shyn PB; Sung JC; Tatli S; Morrison PR; Catalano PJ; Silverman SG
Eur J Radiol; 2014 Apr; 83(4):632-8. PubMed ID: 24529593
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation: a minimally invasive approach in kidney tumor management.
Salagierski M; Salagierski MS
Cancers (Basel); 2010 Nov; 2(4):1895-900. PubMed ID: 24281207
[TBL] [Abstract][Full Text] [Related]
36. [Ultrasound-guided percutaneous cryoablation of renal tumors].
Enikeev DV; Glybochko PV; Alyaev YG; Rapoport LM; Amosov AV; Alekseeva TM; Enikeev ME; Tsarichenko DG; Chinenov DV; Kozmin LD; Dzhalaev ZK; Taratkin MS
Urologiia; 2017 Jul; (3):68-73. PubMed ID: 28845941
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.
Goeman L; Joniau S; Oyen R; Van Poppel H
Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367
[TBL] [Abstract][Full Text] [Related]
38. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors.
Ferakis N; Bouropoulos C; Granitsas T; Mylona S; Poulias I
J Endourol; 2010 Dec; 24(12):1909-13. PubMed ID: 20946062
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
